Volkan Granit

2.0k total citations
15 papers, 118 citations indexed

About

Volkan Granit is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Volkan Granit has authored 15 papers receiving a total of 118 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 5 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in Volkan Granit's work include Amyotrophic Lateral Sclerosis Research (8 papers), Myasthenia Gravis and Thymoma (5 papers) and Neurogenetic and Muscular Disorders Research (5 papers). Volkan Granit is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (8 papers), Myasthenia Gravis and Thymoma (5 papers) and Neurogenetic and Muscular Disorders Research (5 papers). Volkan Granit collaborates with scholars based in United States, United Kingdom and Australia. Volkan Granit's co-authors include Michael Benatar, Joanne Wuu, Stephanie Cosentino, Andrea Malaspina, Caroline McHutchison, Peter M. Andersen, Richard F. Lewis, Mario Saporta, Gary Cutter and Mazen M. Dimachkie and has published in prestigious journals such as Brain, Neurology and Annals of Neurology.

In The Last Decade

Volkan Granit

10 papers receiving 117 citations

Peers

Countries citing papers authored by Volkan Granit

Since Specialization

Citations

This map shows the geographic impact of Volkan Granit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volkan Granit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volkan Granit more than expected).

Fields of papers citing papers by Volkan Granit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Volkan Granit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volkan Granit. The network helps show where Volkan Granit may publish in the future.

Co-authorship network of co-authors of Volkan Granit

This figure shows the co-authorship network connecting the top 25 collaborators of Volkan Granit. A scholar is included among the top collaborators of Volkan Granit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Volkan Granit. Volkan Granit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Skeletal Muscle Biomarkers of Amyotrophic Lateral Sclerosis: A Large‐Scale, Multi‐Cohort Proteomic Study 2025 ·Annals of Neurology ·(unknown), Joanne Wuu, (unknown), Andrea Malaspina, Volkan Granit, (unknown), Anne Cooley, (unknown), Lili Yu, Michael Bidinosti, (unknown), (unknown), Lori L. Jennings, James D. Berry, Lucie Bruijn, Sophie Brachat, Michael Benatar	0
2	Proposed Research Criteria for Mild Motor Impairment as a Prodromal Syndrome in Amyotrophic Lateral Sclerosis 2025 ·Neurology ·Michael Benatar, Xueya Cai, Michael P. McDermott, Volkan Granit, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Christine Stanislaw, Peter M. Andersen, (unknown), Joanne Wuu	1
3	BHV-2100, a First-in-Class TRPM3 Antagonist in Development for the Treatment of Migraine (P7-12.009) 2025 ·Neurology ·Beth Emerson, Anne Pieters, Beth Morris, Andrew T. Lucas, Volkan Granit, (unknown), Joris Vriens, Thomas Voets, Irfan Qureshi, Vladimir Coric, Richard B. Lipton	0
4	Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis 2024 ·EBioMedicine ·Michael Benatar, Eric A. Macklin, Andrea Malaspina, Mary‐Louise Rogers, Eran Hornstein, Vittoria Lombardi, (unknown), Stephanie Shepheard, Iddo Magen, (unknown), Volkan Granit, Jeffrey Statland, Jeannine M. Heckmann, Rosa Rademakers, Caroline McHutchison, Leonard Petrucelli, Corey T. McMillan, Joanne Wuu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	14
5	BHV-2100, a First-in-class TRPM3 Antagonist for the Treatment of Pain (S13.002) 2024 ·Neurology ·Joris Vriens, Jean‐Christophe Vanherck, Arnaud Marchand, Bruce R. Carr, Gene M. Dubowchik, (unknown), Volkan Granit, Lawrence R. Marcin, David Pirman, Patrick Chaltin, Thomas Voets	0
6	Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials 2023 ·Neurology ·Jeffrey T. Guptill, Michael Benatar, Volkan Granit, Ali A. Habib, James F. Howard, (unknown), Richard J. Nowak, Ik Jae Lee, Katherine Ruzhansky, Mazen M. Dimachkie, Gary Cutter, Henry J. Kaminski	15
7	The amyotrophic lateral sclerosis-health index (ALS-HI): development and evaluation of a novel outcome measure 2023 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·(unknown), (unknown), (unknown), Spencer Rosero, (unknown), (unknown), (unknown), Nuran Dilek, (unknown), Joanne Wuu, James B. Caress, Richard Bedlack, Volkan Granit, Jeffrey Statland, Paul Mehta, Michael Benatar, Aaron J. Kaat, Chad Heatwole	0
8	Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches 2022 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Corey T. McMillan, Joanne Wuu, Katya Rascovsky, Stephanie Cosentino, Murray Grossman, Lauren Elman, Colin Quinn, (unknown), (unknown), Volkan Granit, Hannah Briemberg, Sneha Chenji, Annie Dionne, Angela Genge, Wendy Johnston, Lawrence Korngut, Christen Shoesmith, Lorne Zinman, (unknown), Sanjay Kalra, Michael Benatar	19
9	Impact of the COVID‐19 pandemic on patients with myasthenia gravis: A survey of the Myasthenia Gravis Foundation of America MG patient registry 2022 ·Muscle & Nerve ·(unknown), Inmaculada Aban, Tarrant McPherson, Volkan Granit, Michael Benatar, Gary Cutter, (unknown)	7
10	Patient reported impact of symptoms in amyotrophic lateral sclerosis (PRISM-ALS): a national, cross-sectional study 2022 ·EClinicalMedicine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Nuran Dilek, (unknown), Joanne Wuu, James B. Caress, Richard Bedlack, Volkan Granit, Jeffrey Statland, Paul Mehta, Michael Benatar, Chad Heatwole	17
11	Mild motor impairment as prodromal state in amyotrophic lateral sclerosis: a new diagnostic entity 2022 ·Brain ·Michael Benatar, Volkan Granit, Peter M. Andersen, (unknown), Caroline McHutchison, Stephanie Cosentino, Andrea Malaspina, Joanne Wuu	29
12	Harnessing the power of the electronic health record for ALS research and quality improvement: CReATe CAPTURE‐ALS and the ALS Toolkit 2021 ·Muscle & Nerve ·Volkan Granit, (unknown), Joanne Wuu, Jonathan Katz, David Walk, Sumaira Hussain, Jessica Hernández, Carlayne E. Jackson, James B. Caress, (unknown), Nancy A. Smider, Michael Benatar	5
13	Impact of the COVID-19 pandemic on Myasthenia Gravis patients: A survey of the Myasthenia Gravis Foundation of America Registry (1887) 2021 ·Neurology ·(unknown), Inmaculada Aban, Tarrant McPherson, Volkan Granit, Michael Benatar, Gary Cutter, (unknown)	0
14	Yes, we can: Neuromuscular examination by telemedicine 2020 ·Muscle & Nerve ·Mario Saporta, Volkan Granit, Richard F. Lewis, Michael Benatar	7
15	Abnormal spontaneous activity on needle electromyography in myasthenia gravis 2017 ·Muscle & Nerve ·(unknown), (unknown), Volkan Granit, Phyllis Bieri, Steven Herskovitz	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact